SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is facing heavy sell-side pressure following the announcement of a $1 billion convertible senior note offering, which has reignited concerns regarding dilution and the company's long-term capital requirements. While some in the community view the financing as a strategic move to accelerate satellite launches and secure orbital capacity, many retail investors are expressing frustration over the timing and perceived inconsistencies in management's previous capital guidance.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending following a new all-time high fueled by regulatory approval for its AI platform in China and reports of potential AI chip acquisitions to bolster infrastructure. While the stock's breakout has generated significant bullish momentum, community sentiment remains divided between excitement over its AI potential and skepticism regarding its high valuation and reliance on Chinese markets.

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.

AtaiBeckley Inc.

AtaiBeckley Inc. is trending following reports that Eli Lilly is in advanced talks to acquire the company, fueling community excitement over a potential takeover premium. Shareholders and investors are actively debating the rumored valuation, the broader implications for the psychedelic sector, and whether to hold for a bidding war or take profits now.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor is experiencing significant market attention as traders closely monitor high-stakes earnings expectations and implied volatility ahead of the upcoming report. Community discussion is heavily focused on the company's critical role as the primary foundry for the AI supply chain, with many investors debating whether the stock's recent performance represents a buying opportunity or a signal of wider semiconductor sector rotation.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is experiencing intense volatility and downward pressure as investors debate whether the recent sell-off in the broader space sector represents an overcorrection or a fundamental reset. While some market participants express frustration over ongoing share dilution and the stock's failure to maintain momentum, others are actively accumulating shares, pointing to the company's robust backlog and institutional buying as indicators of long-term value despite current bearish sentiment.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is trending as investors react to presidential endorsements and institutional focus on its AI server infrastructure and enterprise hardware growth. The community remains divided, with some highlighting strong relative strength and institutional accumulation, while others express concerns over valuation, insider selling, and potential market volatility.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing increased institutional interest and bullish sentiment as investors pivot toward healthcare as a defensive rotation, with market focus shifting to its upcoming Q2 earnings report. Community discussions are centered on strong long-term fundamentals and the stock's ability to maintain upward momentum, with many monitoring its performance relative to technical resistance levels.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending as investors monitor high-volume manufacturing progress with next-generation EUV lithography tools, fueling debate over the company's long-term foundry turnaround. Community sentiment is deeply divided, with many traders closely watching volatile price swings and sector-wide AI infrastructure concerns while others remain optimistic about the firm's strategic position ahead of upcoming earnings.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

ProShares UltraPro Short QQQ (SQQQ) is seeing heightened activity as market participants navigate concerns over a potential technology sector pullback, geopolitical instability in the Strait of Hormuz, and inflationary pressures. Community discourse remains polarized, with many investors debating the effectiveness of leveraged inverse ETFs as hedging tools amidst ongoing market volatility and speculative AI valuation debates.

SK hynix, Inc. engages in the manufacture and sale of semiconductor products. Its products include dynamic random access memory, flash memory, complementary metal oxide semiconductor image sensor, and others. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is experiencing extreme volatility following its high-profile U.S. debut, with the community actively debating whether the stock's massive premium over its Korean listing represents a sustainable AI-driven valuation or a temporary disconnect prone to an aggressive correction. Traders are closely monitoring the massive discrepancy between the ADR and domestic shares, fueling a divide between those betting on long-term HBM demand and those warning of a potential 'dump' by international market participants.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS https://www.venclextahcp.com/aml/side-effects/ven-aza-safety-profile.html  
Aza +VEN is the BAT for Control Arm Patients and it TOXIC. 
- VIALE-M - M for Maintenance - Large Phase 3 Trial for First Remission Maintenance conducted by $ABBV FAILED 
- VIALE-T - Post Transplant Phase 3 Maintenance Trial - also FAILED. 
 
Look at the VIALE-A Adverse Event Profile - again Aza+VEN for Newly Dxd AML Patients who&#39;re unable to handle Intensive Chemo 7+3 and would have died in weeks/a month with no Treatment. 
 
and 83% of Patients Suffered Severe Adverse Events and 23% of the VIALE-A patients DIED FROM TAKING THE DRUGS... 
BAT - is NOT an Effective Maintenance Treatment ...  
Meanwhile we are seeing and continue to wait for Near Miraculous REGAL Survival P3 ...  
if you don&#39;t know, it Gps doing what its done in all 7 Prior Trials, including 2 Phase 2&#39;s for AML Remission Maintenance - w 4x and 2x OS advantages, then you are a fucking idiot.

El Marti

Jeremy Dworkin

peacewealth7447

Peggy Murphy

5,500% ROI this quarter

bikechain

nick

Review safety data from the VIALE-A clinical trial for VENCLEXTA® + azacitidine - including adverse reactions and lab abnormalities. See full safety and Prescribing Info for more details.

venclexta

VENCLEXTA® (venetoclax tablets) | VIALE-A Trial Safety Data Summary

$SLS Does anyone Know what 83 Serious AR&#39;s Means ? 
how about FATAL ARs 23? 
 
THIS IS THE SUPER BAT Rate of Serious Adverse Reactions Warning Label from the VIALE-A trial - the only 1 of the 3 Viale trials that was Deemed Successful ... 
 
23  
- super BAT My ASS 
https://www.venclextahcp.com/aml/side-effects/ven-aza-safety-profile.html

StockTwits Web

SELLAS Life Sciences Group Inc

Abbvie Inc

  
Aza +VEN is the BAT for Control Arm Patients and it TOXIC. 
- VIALE-M - M for Maintenance - Large Phase 3 Trial for First Remission Maintenance conducted by 

 FAILED 
- VIALE-T - Post Transplant Phase 3 Maintenance Trial - also FAILED. 
 
Look at the VIALE-A Adverse Event Profile - again Aza+VEN for Newly Dxd AML Patients who're unable to handle Intensive Chemo 7+3 and would have died in weeks/a month with no Treatment. 
 
and 83% of Patients Suffered Severe Adverse Events and 23% of the VIALE-A patients DIED FROM TAKING THE DRUGS... 
BAT - is NOT an Effective Maintenance Treatment ...  
Meanwhile we are seeing and continue to wait for Near Miraculous REGAL Survival P3 ...  
if you don't know, it Gps doing what its done in all 7 Prior Trials, including 2 Phase 2's for AML Remission Maintenance - w 4x and 2x OS advantages, then you are a fucking idiot.